Skip to main content
SpringerLink
Log in

Ernährung und Flüssigkeitssubstitution in der letzten Lebensphase

  • Chapter
Schmerzbehandlung in der Palliativmedizin

  • 705 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Argiles JM, Meijsing SH, Pallares-Trujillo J et al (2001) Cancer cachexia: a therapeutic approach. Med Res Rev 21: 83–101

    Article  PubMed  CAS  Google Scholar 

  2. Barber MD, Ross JA, Fearon KC (1999) Cancer cachexia. Surg Oncol 8: 133–141

    Article  PubMed  CAS  Google Scholar 

  3. Bausewein C, Roller S, Voltz R (2000) Leitfaden Palliativmedizin, Urban & Fischer, München, S 380–382

    Google Scholar 

  4. Bentley A, Boyd K (2001) Mangement of nausea and vomiting using clinical pictures. Palliative Medicine 15: 247–253

    Article  PubMed  CAS  Google Scholar 

  5. Body JJ (1999) The symptom of anorexia-cachexia. Curr Opin Oncol 11: 255–260

    Article  PubMed  CAS  Google Scholar 

  6. Bruera E (1997) Anorexia, cachexia and nutrition. Br Med J 315: 1219–1222

    CAS  Google Scholar 

  7. Bruera E (1998) Pharmacological treatment of cachexia: any progress? Support Cancer Care 6: 109–113

    Article  CAS  Google Scholar 

  8. Bruera E, Belzile M, Watanabe S, Fainsinger R (1996) Volume of hydration in terminal cancer patients. Supportive Care in Cancer 4: 147–150

    Article  PubMed  CAS  Google Scholar 

  9. Bruera E, Neumann CM, Pituskin E et al (1999) Thalidomide in patients with cachexia due to terminal cancer: preliminary report. Ann Oncol 10: 857–859

    Article  PubMed  CAS  Google Scholar 

  10. Burge FI (1993) Dehydration symptoms of palliative care. J Pain Symtom and Management 8: 454–464

    Article  CAS  Google Scholar 

  11. Chance WT, Balasumbramaniam A, Dayal R et al (1994) Hypothalamic concentration and release of neuropeptide Y in microdialysates is reduced in anorectic tumor-bearing rats. Life Sci 54: 1869–1874

    Article  PubMed  CAS  Google Scholar 

  12. Clemm C (2001) Ernährungstherapie. In: Höffken K, Kolb G, Wedding U (Hrsg), Geriatrische Onkologie. Springer, Berlin Heidelberg New York Tokyo, S 357–368

    Google Scholar 

  13. Davis MP, Dickerson D (2000) Cachexia and anorexia: cancer’s covert killer. Supportive Care in Cancer 8: 180–187

    Article  PubMed  CAS  Google Scholar 

  14. Dunphy K, Finlay I, Rathborne G, Gilbert J, Hicks F (1995) Rehydration in palliative and terminal care: if not — why not? Palliative Medicine 9: 221–228

    PubMed  CAS  Google Scholar 

  15. Fainsinger R (1996) Pharmacological approach to cancer anorexia and cachexia. In: Bruera E, Higginson I (Hrsg), Cachexia-anorexia in cancer patients. Oxford University Press, Oxford, S 128–140

    Google Scholar 

  16. Fainsinger RL, Bruera E (1997) When to treat dehydration in a terminally ill patients. J Palliative Care 10: 55–59

    Google Scholar 

  17. Fainsinger RL, MacEachern T, Miller M, Bruera E, Spachynsky K, Kuehn N, Hanson J (1994) The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain and Symptom Management 9: 298–302

    Article  CAS  Google Scholar 

  18. Farrand S, Campell AJ (1996) Safe, simple subcutaneous fluid administration. Br J Hosp Med 55: 690–692

    PubMed  CAS  Google Scholar 

  19. Feuz A, Rapin CH (1994) An observational study of the role of pain control and food adaption of elderly patients with terminal cancer. J Am Diet Assoc 94: 767–770

    Article  PubMed  CAS  Google Scholar 

  20. Fox ET (1996) IV hydration in the terminally ill: ritual or therapy? Br J Nurse 5: 41–45

    CAS  Google Scholar 

  21. Gagnon B, Bruera E (1998) A review of the drug treatment of cachexia associated with cancer. Drugs 55: 675–688

    Article  PubMed  CAS  Google Scholar 

  22. Gayle D, Ilyin SE, Plata-Salaman CR (1997) Central nervous system IL-1b system and neuropeptide Y mRNA during IL-1b-induced anorexia in rats. Brain Res Bull 44: 311–317

    Article  PubMed  CAS  Google Scholar 

  23. Higginson I, Bruera E (1996) Practical concepts for clinicians. In: Bruera E, Higginson I (Hrsg), Cachexie-anorexia in cancer patients. Oxford University Press, Oxford, S 185–189

    Google Scholar 

  24. Hirai K, Hussey HJ, Barber MD et al (1998) Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58: 2359–2365

    PubMed  CAS  Google Scholar 

  25. Husebo S, Klaschik E (2000) Flüssigkeitssubstitution in der Terminalphase in Palliativmedizin. Springer, Berlin Heidelberg New York Tokyo, S 249–251

    Google Scholar 

  26. Inui A (1999a) Cancer anorexia-cachexia syndrome: are neuropeptids the key? Cancer Res 59: 4494–4501

    Google Scholar 

  27. Inui A (1999b) Feeling and body-weight regulation by hypothalamic neuropeptides — mediation of the of the actions of leptin. Trends Neurosci 22: 62–67

    Article  PubMed  CAS  Google Scholar 

  28. Inui A (1999c) Neuropeptide Y. A key molecule in anorexia and cachexia in wasting disorders? Mol Med Today 5: 79–85

    Article  PubMed  CAS  Google Scholar 

  29. Kalra SP, Cube MG, Pu S et al (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68–100

    Article  PubMed  CAS  Google Scholar 

  30. Kaye P (1994) Nausea and vomiting. In: A to Z of hospice and palliative medicine. EPL Publication, Northhampton, S 159–164

    Google Scholar 

  31. Klein S, Kinney J, Jeejeebhoy K et al (1997) Nutrion support in clinical practice: review of published data recommendations for the future research directions. Am J Clin Nutr 66: 683–706

    PubMed  CAS  Google Scholar 

  32. Kotler DP (2000) Cachexia. Ann Intern Med 133: 622–634

    PubMed  CAS  Google Scholar 

  33. Lissoni P, Paolorossi F, Tancini G et al (1996) Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 32: 1340–1343

    Article  Google Scholar 

  34. Loprinzi CL, Michalak JC, Schaid DJ et al (1993) Phase III evaluatio of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11: 762–767

    PubMed  CAS  Google Scholar 

  35. Ludwig CA (1997) Flüssigkeitssubstitution in der Terminalphase. In: Aulbert E, Zech D (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, S 595–599

    Google Scholar 

  36. Mantovani G, Maccio A, Massa E et al (2001) Managing cancer-related anorexia/cachexia. Drugs 61: 499–514

    Article  PubMed  CAS  Google Scholar 

  37. Musgrave CT, Bartal N, Opstad J (1995) The sensation of thirst in dying patients receiving IV hydration. J Palliative Care 11: 17–21

    CAS  Google Scholar 

  38. Nelson KA (2000) The cancer anorexia-cachexia syndrome. Semin Oncol 27: 64–68

    PubMed  CAS  Google Scholar 

  39. Nelson K, Walsh D, Deeter P et al (1994) A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer associated anorexia. J Palliat Care 10: 14–18

    PubMed  CAS  Google Scholar 

  40. Ollenschläger G (1997) Tumorkachexie und Ernährung. In: Aulbert E, Zech D (Hrsg), Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, S 556–565

    Google Scholar 

  41. Schwartz MW, Seeley RJ (1997) Neuroendocrine responses to starvation and weight loss. N Engl J Med 226: 1802–1811

    Article  Google Scholar 

  42. Schwartz MW, Woods SC, Porte D et al (2000) Central nervous system control for food intake. Nature 404: 661–671

    PubMed  CAS  Google Scholar 

  43. Smith KL, Tisdale MJ (1993) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680–685

    PubMed  CAS  Google Scholar 

  44. Tisdale MJ (2000) Metabolic abnormalities in cachexia and anorexia. Nutrition 16: 1013–1014

    Article  PubMed  CAS  Google Scholar 

  45. Tisdale MJ (2001) Cancer anorexia and cachexia. Nutrition 17: 438–442

    Article  PubMed  CAS  Google Scholar 

  46. Todorov P, Cariuk P, McDevitt et al (1996) Characterization of a cancer cachectic factor. Nature 379: 739–742

    Article  PubMed  CAS  Google Scholar 

  47. Werni M, Wilkens E, Popp W (2002) Ziel: Verbesserung der Lebensqualität — Ernährung und Flüssigkeitssubstitution in der Palliativmedizin. Wien Klin Wochenschr 3a: 26–30

    Google Scholar 

  48. Wigmore MJ, Ross JA, Falconer JS et al (1996) The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12: 27–30

    Google Scholar 

  49. Wigmore SJ, Fearon KC, Maingay JP et al (1997a) Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 92: 215–221

    PubMed  CAS  Google Scholar 

  50. Wigmore SJ, Plester CE, Ross JA et al (1997b) Contribution of anorexia and hypermetabolism to weight loss in anicteric patients pancreatic cancer. Br J Surg 84: 196–197

    Article  PubMed  CAS  Google Scholar 

  51. Woods SC, Seeley RJ, Porte D et al (1998) Signals that regulate food intake and energy homeostasis. Science 280: 1378–1383

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ärztl. Leiterin d. Station f. Palliativmed. KH Lainz, A-1130, Wien, Wolkersbergenstraß 1

    Michaela Werni-Kourik (OA Dr.)

Authors
  1. Michaela Werni-Kourik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Werni-Kourik, M. (2006). Ernährung und Flüssigkeitssubstitution in der letzten Lebensphase. In: Schmerzbehandlung in der Palliativmedizin. Springer, Vienna. https://doi.org/10.1007/3-211-32188-8_22

Download citation

  • DOI: https://doi.org/10.1007/3-211-32188-8_22

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25289-5

  • Online ISBN: 978-3-211-32188-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation